Article

John Serio and Christopher Head author "Outsourcing Strategies for Maximizing Drug Exclusivity"

20 December 2022

Partner, John Serio and Associate, Christopher Head author "Outsourcing Strategies for Maximizing Drug Exclusivity". The article, published in Outsourced Pharma, highlights the importance of verifying the details of contractual agreements between pharmaceutical companies and any contract development and manufacturing organization (CDMO) they intend to utilize when looking to outsource the development process of getting a drug target commercialized.

Discoveries can be made during this process that are novel and strategically relevant to the life cycle of a product, and it is critical that the ownership of these fresh insights and associated intellectual property is made clear. Pharmaceutical companies that are aware of the potential for additional patentable subject matter are better equipped to extend patents or regulatory positions. 

Read the full article here.

This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.

Share

Join the club

We have lots more news and information that you'll find informative and useful. Let us know what you're interested in and we'll keep you up to date on the issues that matter to you.
Sign up here